Sanner acquisition strengthens company's leadership in effervescent packaging market
Acquisition of Jaco enables Sanner to operate as a system supplier.
Sanner has acquired Plastina Holding AG, the parent company of Jaco S.A., based in Kirchheim, Germany. Through the merger, Sanner now advances to the global market leader for effervescent packaging.
Sanner is known as market leader for desiccant packaging in the global pharmaceutical and healthcare sector. Jaco S.A. is a leading manufacturer of printed and unprinted plastic tubes for effervescent tablets. "Our product portfolios complement each other ideally," says Dirk Mähr, Managing Director of Sanner. "As a result of the merger, we have significantly strengthened our market position and have become the world market leader for effervescent packaging.” In 2016, Sanner generated annual sales of 63.7 million euro, whereas Jaco achieved around 13 million euro.
"Together, we offer our customers one of the most comprehensive ranges of tubes and closures, combined with numerous decoration possibilities. This allows us to operate as a system supplier in the future,” says Tharcisse Decker, Managing Director of Jaco. “Apart from the strong French and European market, we are now also able to enter new markets such as the Middle East or Africa more effectively,” Dirk Mähr adds. Moreover, Jaco’s experience in printing technology can be used for new products, while Sanner’s competencies in research and development are of great advantage for joint, innovative projects.
The acquisition will have no effect on the employees or the production of both companies. Customers will be served by the sites in Bensheim and Kirchheim. The company name Jaco SA will remain unchanged for the time being. The former owners of Jaco S.A have withdrawn from business. The parties agreed on keeping the purchase price confidential.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance